Balyasny Asset Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-86,229
| Closed | -$1.24M | – | 2000 |
|
|
2025
Q1 | $1.24M | Buy |
86,229
+71,620
| +490% | +$1.03M | ﹤0.01% | 1291 |
|
|
2024
Q4 | $233K | Buy |
+14,609
| New | +$233K | ﹤0.01% | 1704 |
|
|
2023
Q3 | – | Sell |
-13,182
| Closed | -$337K | – | 1761 |
|
|
2023
Q2 | $337K | Buy |
+13,182
| New | +$337K | ﹤0.01% | 1563 |
|
|
2022
Q4 | – | Sell |
-30,836
| Closed | -$672K | – | 2323 |
|
|
2022
Q3 | $672K | Sell |
30,836
-323,173
| -91% | -$7.04M | ﹤0.01% | 1508 |
|
|
2022
Q2 | $9.68M | Buy |
354,009
+65,163
| +23% | +$1.78M | 0.03% | 544 |
|
|
2022
Q1 | $9.68M | Sell |
288,846
-19,063
| -6% | -$639K | 0.03% | 553 |
|
|
2021
Q4 | $10.7M | Sell |
307,909
-23,085
| -7% | -$800K | 0.04% | 518 |
|
|
2021
Q3 | $10.3M | Buy |
+330,994
| New | +$10.3M | 0.04% | 477 |
|
|
2020
Q4 | – | Sell |
-207,941
| Closed | -$6.91M | – | 1146 |
|
|
2020
Q3 | $6.91M | Buy |
+207,941
| New | +$6.91M | 0.05% | 420 |
|
|
2019
Q4 | – | Sell |
-6,296
| Closed | -$236K | – | 1033 |
|
|
2019
Q3 | $236K | Buy |
+6,296
| New | +$236K | ﹤0.01% | 935 |
|
|
2018
Q3 | – | Sell |
-6,317
| Closed | -$362K | – | 1430 |
|
|
2018
Q2 | $362K | Buy |
+6,317
| New | +$362K | ﹤0.01% | 1271 |
|
|
2018
Q1 | – | Sell |
-185,594
| Closed | -$8.57M | – | 1731 |
|
|
2017
Q4 | $8.57M | Buy |
+185,594
| New | +$8.57M | 0.03% | 579 |
|